Teniposide granted marketing approval.
D002648:Child; D017277:Drug Approval; D006801:Humans; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy; D013713:Teniposide / Q000494:pharmacology / Q000627:therapeutic use*
D013713:Teniposide